MEGHAN DAY: Open Payments
NPI 1285345140 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,414 in 176 payments from 26 companies in 2025. Trend: 2023 $3,852 · 2024 $5,238 · 2025 $4,414
Food & beverage: $4,414
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 19 | $693 |
| ABBVIE INC. | 15 | $447 |
| UCB, Inc. | 6 | $346 |
| Galderma Laboratories, L.P. | 8 | $341 |
| Regeneron Healthcare Solutions, Inc. | 9 | $299 |
| Amgen Inc. | 8 | $256 |
| Incyte Corporation | 5 | $208 |
| E.R. Squibb & Sons, L.L.C. | 14 | $188 |
| GENZYME CORPORATION | 6 | $188 |
| Novartis Pharmaceuticals Corporation | 9 | $177 |
Products named: ADBRY, SKYRIZI, Bimzelx, DUPIXENT, Otezla, ANZUPGO, NEMLUVIO, OPZELURA.
Industry payments across AZ — which companies pay providers there.
